Acasti to Present at Two Scientific Forums
Laval, Québec, CANADA – May 1, 2014 – Acasti Pharma Inc. (“Acasti” or the “Corporation”) (NASDAQ:ACST – TSX-V:APO), an emerging biopharmaceutical company focused on the research, development and commercialization of new krill oil-based forms of omega-3 phospholipid therapies for the treatment and prevention of certain cardiometabolic disorders, announced today that it will be presenting at two upcoming scientific forums. The presentations will be on Acasti’s Phase II Open Label (COLT) trial results, previously announced in August 2013. The conferences include:
· The National Lipid Association Scientific Sessions 2014 to be held in Orlando, Florida from May 1-4, 2014.
Acasti will present on Friday, May 2 from 11:30 to 12:30 and Saturday, May 3 from 12:00 to 1:00
· The 82nd Congress of the European Atherosclerosis Society to be held in Madrid, Spain from
May 31-June 3, 2014. Acasti will present on Sunday, June 1 from 12:30 to 3:00 and Monday, June 2 from 12:30 to 3:00
The presentation will be available on the investor section of Acasti’s website under events and presentations, at the conclusion of the National Lipid Association conference: acastipharma.com/en/investor-relations/events |
